NICE backs Roche's Kadcyla for HER2-positive early breast cancer
admin 11th May 2020 Uncategorised 0Around 800 people will be eligible for treatment with Kadcyla More: NICE backs Roche's Kadcyla for HER2-positive early breast cancer Source: News
read more